Developing New Ocular Therapies that Help Patients See Their Very Best Throughout Their Lives

PanOptica, Inc. is a private, venture-backed biopharmaceutical company focused on licensing and developing a portfolio of exciting and innovative therapeutics for major ophthalmic diseases.

Year Invested: 2010
Location: Bernardsville, NJ

Recent News

April 15, 2014
PanOptica Raises $45 Million to Finance Clinical Development of Anti-VEGF Eye Drop for Wet AMD

Read More News

Associated Team Members

Kevin Starr